CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, 24 Week Parallel-group Placebo-controlled (Phase 2) Pilot-study of High Dose Omega 3 (DHA) in People at Risk for Dementia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03926351
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:19.412066+00:00
Published At: 2019-04-24T00:00:00+00:00
Record Updated At: 2019-04-24
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Dementia", "Inflammation", "Mild Cognitive Impairment", "Cognitive Decline", "SCD", "Cognitive Dysfunction", "Pathologic Processes", "Brain Diseases", "Central Nervous System Diseases", "Nervous System Diseases", "Neurocognitive Disorders", "Mental Disorder", "Cognition Disorders"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-04-24"
protocolSection.identificationModule.nctId: "NCT03926351"
protocolSection.identificationModule.officialTitle: "A Randomized, 24 Week Parallel-group Placebo-controlled (Phase 2) Pilot-study of High Dose Omega 3 (DHA) in People at Risk for Dementia"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.